Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group.

Groth, C G; Bäckman, L; Morales, J M; Calne, R; Kreis, H; Lang, P; Touraine, J L; Claesson, K; Campistol, J M; Durand, D; Wramner, L; Brattström, C; Charpentier, B

Groth, C G; Bäckman, L; Morales, J M; Calne, R; Kreis, H; Lang, P; Touraine, J L; Claesson, K; Campistol, J M; Durand, D; Wramner, L; Brattström, C; Charpentier, B.

Affiliation

Groth CG; Huddinge Hospital, Stockholm, Sweden.

Transplantation ; 67(7): 1036-42, 1999 Apr 15.

Article in En | MEDLINE | ID: mdl-10221490

Subject(s)

Immunosuppressive Agents/therapeutic use; Kidney Transplantation; Sirolimus/therapeutic use; Adult; Aged; Cyclosporine/therapeutic use; Female; Humans; Immunosuppressive Agents/adverse effects; Kidney/physiopathology; Male; Middle Aged; Osmolar Concentration; Patient Dropouts; Pilot Projects; Sirolimus/adverse effects; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Sirolimus / Immunosuppressive Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Transplantation Year: 1999 Document type: Article Affiliation country: Sweden Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links